Diagnostics
Educational materials that cover basics of hepatitis C testing and barriers to getting diagnosed.
Materials in this section
Acceptability of Hepatitis C Testing Using Point-Of-Care Testing and Dried Blood Spot Collection Among People at Risk of Hepatitis C Infection
A study evaluated the acceptability of dried blood spot and point-of-care testing among people at risk of HCV infection and examined the circumstances in which such testing is most preferred. More
“It’s Not Just Running the Test”: Operator Experiences of Implementing a Decentralised Hepatitis C Point-Of-Care Testing Program in Australia
A study explored operator experiences, including the challenges and enablers, of implementing point-of-care testing as part of a National Point-of-Care Testing Program. More
First Self-Test for Hepatitis C Virus
Whereas affordable HCV self-testing can improve HCV screening, the price and availability of virologic testing, required to confirm HCV diagnosis prior to treatment, remains a major obstacle to HCV elimination in LMICs and must be urgently addressed. More
Usability and Acceptability of Self-Testing for HCV Exposure in Pakistan
A study assessed the usability and acceptability of HCV antibody self-testing in a high HCV prevalence informal settlement in Karachi, Pakistan. More
Testing and Treating Hepatitis C in a UK Remand Prison
An article explores a hepatitis C testing program implemented at a remand prison, highlighting the role of oral swabs and peer involvement in increasing testing rates. More
Priorities in Planning Hepatitis B and C Testing Services: New WHO Operational Guide
The purpose of the guide is to support countries in developing policies that define a strategic mix of hepatitis B and C testing approaches, tailored to their unique situation ensuring an impactful national response to the hepatitis epidemic. More
New Research Supports Universal HCV Screening Over Risk-Based Testing
The study found 1.4 million people aged 12-59 with current HCV infection, including over 500,000 without injection drug use history. More
Point-of-Care HCV RNA Test Could Expedite Diagnosis, Treatment in High-Risk Settings
Findings support the feasibility and clinical performance of Xpert HCV, the first FDA-approved point-of-care test for diagnosing HCV, in a nonclinical justice setting. More
Barriers and Enablers to Point-Of-Care HCV Testing in a Needle and Syringe Program in Canada
Using an intersectionality lens to explore barriers and enablers to hepatitis C point-of-care testing: a qualitative study among people who inject drugs and service providers More
Barriers and Facilitators to Viral Hepatitis Testing in Uzbekistan
Barriers and facilitators to viral hepatitis testing in Uzbekistan: scoping qualitative study among key stakeholders, healthcare workers, and the general population More